SHANGHAI HENLIUS BIOTECH INC. (SGBCF)
Clinical trial NCT07533708 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-25 → 2026-07-30
Clinical trial NCT07533708 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-05-25 → 2026-07-30
Clinical trial NCT06085144 updates: 1. completion date: 2026-04-01 → 2028-04-01 2. primary completion date: 2026-04-01 → 2028-04-01
Clinical trial NCT07496450 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 4000 → 4050 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06609265 updates: 1. status: WITHHELD → RECRUITING 2. start date: not set → 2025-05-01 3. completion date: not set → 2027-11-01 4. primary completion date: not set → 2027-05-01 5. enrollment: not set → 140 participants 6. study type: not set → INTERVENTIONAL 7. enrollment type: not set …
Clinical trial NCT03215095: completion date: 2026-07-01 → 2027-07-01.
Clinical trial NCT06493903 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2026-06-30 → 2026-05-25 3. enrollment: 40 → 39 participants 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT07428408 updates: 1. start date: 2026-02-25 → 2026-08-25 2. completion date: 2026-09-01 → 2026-11-01 3. primary completion date: 2026-07-01 → 2026-09-10
Clinical trial NCT07504601: start date: 2026-08-13 → 2026-08-16.
Clinical trial NCT06131398 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-07-21 → 2026-07-22 3. primary completion date: 2026-07-21 → 2026-07-22
Clinical trial NCT06050122 updates: 1. completion date: 2026-08-01 → 2026-10-01 2. primary completion date: 2026-08-01 → 2026-10-01